In the in vivo 6-OHDA toxin model of Parkinson’s disease, the recombinant MANF protects the dopaminergic cell bodies of the substantia nigra (Voutilainen et al., 2009; Hao et al., 2017). This evidence concerns the gene MANF and Parkinson disease.